Homepage
About Therabene
Pipeline
Publications
Contact us
More
AI-Integrated QSAR Modeling for Enhanced Drug Discovery: From Classical Approaches to Deep Learning and Structural Insight
September 29. 2025
Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment.
August 08. 2024
An Integrated Approach of Combining In-Silico Screening with Experimental Validation for Novel Degraders
February 22, 2024
The upcoming AACR-NCI-EORTC International Conference
October 22–26, 2025
Therabene Inc. presented AI-driven degrader therapeutics at Massachusetts Life Sciences Center (MLSC) and looks forward to expanding this partnership.
September 11, 2025
Therabene Inc. Announces Positive Preclinical Results for Two Promising New Molecules in Collaboration with Biocytogen
November 21, 2024
Therabene Inc. Press Release 2: Therabene Inc. Appoints Dr. Oscar L. Kashala as Chief Medical Officer and Executive Vice President of Global Clinical Development
August 06, 2025
Therabene Inc. Press Release 1: Therabene Inc. Announces Positive Preclinical Results for Two Promising New Molecules in Collaboration with Biocytogen
Mario DiPaola: Who's Who of Top Executives
August 7, 2024
Mario DiPaola: Creating Legacy in Biotechnology and Pharmaceuticals
December 1, 2023
